Top Markets
Coin of the day
Neurizon Therapeutics Limited Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ
Clasificación en acciones #27538
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Precio por acción
$0.0416118
Capitalización bursátil
$32.25M
Cambio (1 día)
-1.67%
Cambio (1 año)
-59.58%
País
AU
Comercio Neurizon Therapeutics Limited (NUZ)

Categoría

Historial del precio de la acción de Neurizon Therapeutics Limited (NUZ)
Precio más alto de cierre: $0.04 el 2026-08-01

Precio más bajo de cierre: $3.11 el 2001-10-01
Historial del precio de la acción de Neurizon Therapeutics Limited desde 2001 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -8.62%
2025 -37.70%
2024 50.11%
2023 61.50%
2022 -33.17%
2021 -20.54%
2020 20.68%
2019 171.67%
2018 -30.35%
2017 4.90%
2016 -29.98%
2015 -55.93%
2014 -33.04%
2013 25.44%
2012 -54.31%
2011 -8.75%
2010 -46.71%
2009 152.12%
2008 -65.75%
2007 -55.38%
2006 -27.70%
2005 -34.70%
2004 20.98%
2003 69.43%
2002 -28.84%
2001 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$759.01 6.64%
CH